Open access peer-reviewed chapter

Insights into the Interaction of Milk and Dairy Proteins with Aflatoxin M1

Written By

Fabio Granados-Chinchilla

Submitted: September 28th, 2015 Reviewed: April 4th, 2016 Published: September 7th, 2016

DOI: 10.5772/63433

Chapter metrics overview

1,905 Chapter Downloads

View Full Metrics


In this chapter, up-to-date data regarding the nature of protein interaction with a contaminant such as aflatoxin M1 (AFM1) is detailed. Considering that AFM1 is a relevant toxin present in milk and dairy products, it is important to understand such interaction. With this in mind, some specific features of protein chemistry and structure are discussed. AFM1 presence and origin in milk and the latest approaches in AFM1 chemical analysis with special attention to sample preparation techniques to eliminate milk protein–AFM1 interaction will also be addressed. Emphasis will be given to the interaction of AFM1 with whey proteins of which little has been described. In order to represent such interactions, recent scientific evidence is briefly discussed which describes the outcome, stability, and distribution of the toxin among the fractions, especially during the cheese-making process. An in silico model is presented in which some details of the AFM1-protein interactions are described. Finally, two technological applications of proteins in the food industry which are affected negatively by AFM1 contamination, are provided as an example of how the contaminant has a deep relationship in protein behaviour.


  • aflatoxin M1
  • whey
  • milk
  • dairy
  • products
  • protein interaction

1. Introduction

1.1. Milk structure

Milk is a rather complex biological fluid that includes components such as fats, proteins, and many other constituents; this means that multiple chemical equilibriums are at work within the liquid. Proteins throw additional complexities to the mix as they can exhibit amphoteric and zwitterion behaviour. Each interaction established by or among proteins may be mediated by hydrophobic pockets, multiple ionic bridging, aromatic ring staking, and henceforth.

Casein, a major phosphoprotein found in milk is composed of several casein fractions that are distinguished by electrophoresis and are designated as α-, β-, and k-caseins (in order of decreasing mobility at pH 7.0). In bovine milk, casein composition, in mg mL−1, consists approximately as follows: αs1 (12–15); αs2 (3–4); β (9–11); and k (2–4) [1, 2]. These fractions vary in molecular weight, isoelectric point, and level of phosphorylation. It is important to keep in mind these structural features since during milk clotting, k-casein is the fraction involved directly in enzymatic cleavage by chymosin during the cheese making process [3].

For the following discussion, the composition of major milk proteins will be fundamental. In cow milk, for example, the protein composition during seasons vary between 33.8–34.8, 31.2–32.6, 15.5–16.2, 2.0–2.1, 9.6–9.9, and 5.6–6.5 g protein/100 g total protein for α-, β-, and k-casein, α-lactalbumin, β-lactoglobuin, and other proteins (e.g. bovine serum albumin and lactoferrin) [4].

Casein micelles are spherical in shape, with a diameter ranging from 50 to 500 nm (average ca. 120 nm). The more recent model for casein micelle structure is the ‘dual-bonding’ model suggested by Horne [59]. This model proposes that micelle structure is governed by a balance of hydrophobic interactions and colloidal calcium phosphate-mediated cross-linking of hydrophilic regions. This micelle is stabilized by k-casein providing both steric and electrostatic repulsion.

The hydrofilic fraction of milk includes several components, mostly sugars (i. e. lactose, unique to milk/dairy products) and water-soluble proteins (whey proteins). Lactose is a disaccharide composed of a molecule of galactose and glucose connected through a β(1→4) glycosidic bond. Lactose is the primary osmotic component of the milk whose principal biological function is regulating milk secretion. Hence, lactose is the steadiest component in milk, averaging 4.6%, and is unique to this biological fluid [10]. Whey proteins include α-lactalbumin, β-lactoglobulin, blood serum albumin, and immunoglobulins and account for 17% of proteins. Milk proteins also contain fat globule membrane proteins and a large variety of enzymes and hormones [11]. An extensive analysis of the chemistry and biochemistry involved in dairy foods is in Fox and co-workers’ book [12]. Additional structural information regarding milk protein is to be discussed later in the chapter.

1.2. Aflatoxin M1 in dairy products

Aflatoxins are bis-furanocoumarin secondary metabolites produced by some species of filamentous fungi under specific conditions. Fungi that are capable of producing these contaminants are ubiquitous in the environment and have been identified in a wide array of foods (especially cereals and grains) including animal feeds (commodities in which aflatoxins are heavily regulated). Aflatoxins such as B1 and G1 are produced mainly by the Aspergillus species A. parasiticus, A. flavus, and A. nomius [13, 14] using a biosynthetic route shared with norsolorinic acid [15]. Production of these toxins is favoured in tropical and subtropical climates [16, 17] both before harvest and during storage. These toxins exert negative effects in humans and animals including reproductive, immunological, and weight gain issues, among several others. It has already been established that these compounds are carcinogens and teratogenic [16, 18].

In dairy products, the most relevant toxins are AFM1 and M2 which are hydroxylated metabolites of aflatoxin AFB1 and B2, respectively. For example, dairy cows upon ingestion of contaminated feed discard these metabolites (generated during cytochrome P450-mediated detoxification) through urine, faeces, and milk [16, 19]. The toxin is secreted into milk, with an elapsed time of about 12 hours and a peak time of approximately 24 hours. Moreover, Veldman and co-workers [20] have demonstrated that B1 to M1 toxin carryover is proportional to the milk yield and high throughput cows (i.e. > 25 kg day−1) and was estimated to be 2.66 ± 1.24%. However, a more recent analysis has estimated carryover as high as 6.2% [21].

AFM1 is a relatively small molecule (328.3 g mol−1) which exhibits slight affinity towards water (10–30 μg mL−1); hence in milk, it is partitioned into the water and cream parts of milk. It also can be bound to milk proteins [22]. In the case of AFM1 in milk, one may expect that no homogeneous distribution will be encountered. Considering the semipolar characteristics of AFM1, a strong relationship between casein and the toxin may be expected. In fact, appraisals have estimated that 30% of AFM1 is associated with milk non-fat solids. Milk processing usually has a dramatic effect on AFM1 concentration. Enrichment of the non-fat solid portion with AFM1 usually results from fat separation. For example, buttermilk usually retains higher concentrations of toxin when prepared from naturally contaminated cream, a similar situation occurs during skim-milk manufacturing. Though some reports may contradict one another, in general, no AFM1 reduction has been found when preparing other dairy products like cheese and yogurt.

Cheese processing usually results in the accumulation of AFM1 in the curd; this is especially the case for matured cheeses. It has been suggested that this phenomenon is due to AFM1-protein interactions (e.g., with casein the major protein present in cheese [96 g casein/100 g cheese]). However, contrasting data has been offered towards the contamination of the whey fraction. This is relevant since whey products (previously considered just a by-product of cheese manufacturing) have found important applications in the food industry.

All these data hints toward a profound processing and technological effect on the structure and composition of dairy products (e.g. temperature may influence immunoglobulins, which are related to the behaviour of fat globules and casein micelles) and intricate the interactions between AFM1 and other dairy components, including whey proteins, further still [23]. Structural modifications also occur to milk when industrial processing takes place here; milk fat globules are reduced in size (< 1 μm diameter; [24]) and are dispersed uniformly through the rest of the fluid, preventing creaming of the milk. Other relevant factors responsible for differential distribution are the degree of milk contamination, milk quality, and cheese-processing techniques, extraction technique, methodology, and expression of the results. These interactions are discussed below in more detail.

Toxin elimination from food and feed is problematic as these compounds have shown to be thermally stable [25, 26] and may prevail in foods for long periods of time [27, 28]. For example, AFM1 is not deactivated during unit operations common to milk processing such as pasteurization or UHT treatment [29] and it is found in dairy products and have been reported to concentrate in cheese [30].


2. Recent advances in aflatoxin M1 determination in milk and dairy products

Due to its carcinogenic potential, contamination of milk and dairy products with AFM1 may generate risk to humans and animals. Hence, it is considered as a public health concern. Considerable efforts have been made towards evaluating concentrations of AFM1 in dairy products. Complex matrices (especially those with high protein and lipid concentrations) make mycotoxin screening methods difficult, and this matrix effect must be overcome. Method for AFM1 quantification must be able to eliminate matrix interferences and determine AFM1 accurately. Some standardized methods as ISO 14501:207 (IDF 171:2007) [31] and AOAC 2000.08 [32] have been issued using modern quantification techniques and considering several paramount aspects of matrix interference. To eliminate proteins and lipids during the usual chromatographic method developing process, analysts must resort to sample pre-treatment procedures [33]. Conventional methods to achieve adequate sample treatment include, among the most popular, high-speed centrifugation, liquid-liquid extraction, solid phase extraction, and immunoaffinity separation [34].

However, methods for other more complex milk products are still lacking. This void has been filled in recent years by research involving chemical approaches and improvements in sample pre-treatment techniques. Methods for the determination of AFM1 in matrices other than milk such as butter, yogurt, cheese, and sour cream have also been developed (Figure 1) [30, 35, 36].

Figure 1.

A 2D and B 3D rendering of the aflatoxin M1 structure. 3D structure minimized energy using MM2 calculations (total energy of 46.7868 kcal mol−1); pink-coloured beads represent non-bonding electron pairs.

2.1. Magnetic nanoparticles

Recently, modified magnetic nanoparticles coated with 3-(trimethoxysilyl)-1-propanthiol and modified with ethylene glycol bis(mercaptoacetate) were used as sorbent [37]. In this method very good results were reported which resulted in a novel, very specific, sensitive method for the determination of AFM1 in liquid milk. Since authors Hashemi and Taherimaslaka reported that magnetic particles may be reused, and considering that is a relative inexpensive sample preparation treatment, a modified version of this approach may very well, in the future, be suited as a food technology to remove AFM1 from milk in bulk. However, practical costs may hinder a future application.

In this case, the sorbent includes two thiol and carbonyl groups [37]. Thus, it can be concluded that electrostatic interactions through S and O atoms (respectively) are responsible for the interaction with the lactone ring and –OH group in furan ring of AFM1. This type of interaction has also been reported to be responsible for the adsorption of AFB1 by clays. Said interactions seem to be sufficiently strong to disrupt AFM1-matrix interactions. Evidence from the interactions that result from AFM1 and the sorbent ligands may be used as clues to help elucidate possible interactions of amino acid residues and AFM1 within proteins. For example, one may hypothesize that residues such as Trp/Phe, Cys/CY2, Met, and Asp/Asn or Glu/Gln, through an aromatic ring, sulfur groups, and carboxylic acids, respectively, are responsible for interacting with AFM1.

2.2. Chemically-based sorbents

A recent report has described an automated analysis of aflatoxin M1 in milk and other dairy products using tandem mass detection. In this case, two liquid-liquid sequential extractions followed by a solid phase extraction were applied before HPLC analysis. Acetonitrile and salt were used both as a solvent system and protein denaturing/precipitation agents. In this case, Campone and coworkers [38] use an additional cleaning step using 10 mL/100 mL aqueous methanol before introducing the sample in C18 cartridges. Organic phase dilution is accomplished by adding water to the extract containing the analyte; this is a very common practice especially when using SPE/IAC columns. This practice usually results in particle agglutination in the solution when the water is added; this hinders the extraction process as the SPE/IAC pores are obstructed. The extraction steps carried out, achieve signals with no significant matrix interference and limits of detection that are below those required by the EU in milk and dairy products (EU Regulation 1881/2006) [38].

Another recent assay used Oasis® HLB hydrophilic balance, to extract AFM1 with excellent recoveries (92.8%; [39]). Previously, similar results were obtained for powdered milk but using fluorescent analysis instead of mass detection [40]. These specific types of sorbents are based on a copolymer which exploits both in the π-π interaction of divinylbenzene and hydrophilic characteristics of N-vinylpyrrolidone, is a water-wettable polymeric sorbent stable at pH from 1 to 14 ( Accessed 09 Jan 2016). This sorbent has found a widespread application for biological sample pre-treatment because it prevents access to matrix components, such as proteins. However, in order to obtain good results, pH and extraction solution composition must be carefully adjusted. Unequivocally, pH plays a pivotal role here as protein tridimensional structure is dramatically affected by the hydronium ion activity in specific media. In this particular research, the results indicated that the best signal was obtained at pH 5.0 of crude extraction solution with 100% methanol as the eluting solution [39]. Structural differences and principles between several sorbents based technologies may be found in the paper by Boonjob and co-workers [41].

2.3. Molecular imprinted polymers

Lately, another methodological novelty in using molecularly imprinted polymers has emerged; some toxins (e.g. EASIMIP™ Patulin, R-Biopharm, Darmstadt, Germany) are already commercially extracted through molecularly imprinted polymers as column sorbents. These sorbents are tailor-made structures with an encoded selectivity toward a given analyte [42]. Using AFB1 as a template and a methacrylate moiety as an electron acceptor, Wei and coworkers suggested that the extraction mechanism involved all the oxygen atoms in the AFM1 molecule [43]. This evidence is another possible mechanism of interaction. Despite AFM1 being a relatively simple molecule, it exhibits multiple interaction sites; this is further aided by the fact that a slight torsion is expected in the furan ring when considering a spatial 3D/MM2 minimized structure model. Moreover, Wei and coworkers also indicated that matrix compound removal was more efficient using the sorbent that has immunoaffinity-based counterpart. Despite the advantages in terms of analyte specificity of immunoaffinity clean-up based approach for quantification of AFM1 in dairy products, this technology is not without some drawbacks. Toxin adsorption may be limited due to antibody interferences of other matrix compounds, or extraction may be hindered by the interaction of the toxin with matrix components [44]. In fact, chemical based solid phase extraction sorbents may have an advantage over immunoaffinity column in terms of interacting with matrix components due to steric hindrance due to the space occupied by the antibodies used to prepare the latter.

Hence, the interaction of AFM1 with proteins and other matrix components has demonstrated to have analytical consequences. More recently, other methods have used a more direct approach to circumvent poor analytical performance parameters (e.g. improve unsuitable limits of detection, screen interfering matrix co-eluents, reduce or eliminate undesirable interactions with matrix components, and mend methods with low recoveries) to unequivocally identify and determine the exact concentrations of this contaminant which is found in every level in milk products.

2.4. Enzymatic-based approaches

When using a commercial immunoaffinity column during a diagnosis for the determination of AFM1 in three dairy products, relatively low recoveries have been observed when analyzing fresh cheese samples and sour cream [45]. Interestingly, no such effect was seen in ready-to-consume fluidized milk, and this may respond to a technological advancement in immunological sorbents (toxin-specific antibodies coupled to gel particles). Considering that recoveries in cheese and sour cream were lower than expected using a direct extraction with methanol approach and in an effort to reduce the amounts of organic solvents (specially chlorinated solvents) used during the toxin extraction process, our research group hypothesized that dairy proteins and fats played a relevant role in sequestering AFM1, hence limiting its contact with the extraction solvent. This is supported by the fact that analytical recoveries increase dramatically when proteolytic and lipolytic enzymes are added as part of sample treatment previous to the extraction mixture [45]. Later on, Pietri and coworkers [46] used pepsin digestion in a similar fashion, corroborating Chavarría and coworkers recent findings. In some degree these results also support, at least indirectly, that proteins derived from dairy products, such as α-lactalbumin/β-lactoglobulin and casein, indeed interact with AFM1.

2.5. Outlooks

Methodological approaches when determining AFM1 are of relevance since matrix components interfere with the extraction and recovery of the toxin, in particular for fluid milk (and foods derived thereof) since it is a rather complex biological fluid. Considering the nature of the samples tested using the methods stated before, is not surprising that analytical extraction must require stronger conditions when treating other dairy products other than milk. In this regard, for example, Holstein and Jersey's milk (Bos taurus) contain, in average, 3.5 to 5.5 and 3.1 to 3.9 fat and protein, respectively. However, when considering the cheese product, even a tenfold increase in concentration may be expected both in fat and protein, in the case of sour cream, up to a fivefold increase in fat may be expected, retaining similar concentrations in protein. Methods which rely on techniques that involve direct surface interaction with the toxin during sample preparation steps (or during measurement) interaction with the toxin, may find hindrance in matrix components of milk and other dairy products during analysis. For example, caseins are known as surface blocking agents. This may be especially important in methods using biosensors (e.g. the recently applied immuno-chip technology [47] or electrochemical immunosensor [48], direct spore adsorption [49] or lateral flow immunoassay [50]). An excellent review by Adami and co-workers [51] considers sample preparation techniques prior to in depth analysis.


3. Evidence of AFM1 association with milk proteins

3.1. Experimental indications

Though the results of several investigations have showed a close relationship of AFM1 to casein [28, 52], a lot of research reinforce the fact that a significant part of toxin concentration lose out through whey, a fact which is especially interesting considering the poor solubility of AFM1 in water [22]. Hence, its retention or transport along the cheese/whey fraction may be assisted by other molecules, such as proteins, using non-covalent interactions.

The earlier report revolves around the interaction of AFM1 with dairy proteins such as casein was performed by Brackett and Marth [53]. Therein, a simulated milk ultrafiltrate with casein micelles or containing AFM1, was dialyzed against each other, and more AFM1 was found in the casein-containing solution. Furthermore, AFM1 contaminated milk treated with proteolytic enzymes demonstrated that higher concentrations of the toxin were found after the enzymatic treatment when compared with the control, which in turn suggested AFM1 binding by milk proteins. The affinity of AFM1 towards dairy protein fractions was firstly investigated in depth by Govaris and co-workers [54] which described the distribution of AFM1 between whey and curd during cheese manufacturing [54]. Their results showed that 40–60% of the total AFM1 amount was retained in the whey fraction. In this particular case, Govaris and co-workers studied Teleme cheese which is a soft cheese with 50.3–57.2 moisture, 15.2–17.7 protein, and 42–43 fat-in-dry matter, in g/100 g. To be able to compare such results with data obtained for other types of cheese, manufacturing and processing of Teleme cheese must be accounted for, a detailed report can be found in a chapter written by Pappa and Zerfiridis [55]. Other researchers since then have corroborated these results obtaining similar data [54, 56, 5760].

Other results demonstrated that the highest concentration of the toxin is found in the curd [5759, 61, 62]. According to some authors [57, 62], ca. 60% of the AFM1 is found in the curd. Kamkar et al. found an increase of threefold of the content of AFM1 in curd versus that found in whey. Since usually higher concentration of AFM1 are found in cheese [56, 61], concentrations of the contaminant can be considered as cheese is produced from several litres of milk.

Recently obtained data, gathered during the manufacture of fresh Turrialba cheese (a very distinct and recognizable Costa Rican cheese with < 55 moisture, ≥ 14,5 protein, ≥ 18,5 fat-in-dry matter, acidity 0.1-0.3 and 1.5-2 salt, in g/100 g), indicate that whey proteins have a much more affinity towards AFM1 than casein. An in vitro assay using exact quantities of both AFM1 and proteins showed that solutions of α-lactalbumin and casein require concentrations of 2.5 g/100 mL and 7.5 g/100 mL, respectively, to obtain trivial concentrations of AFM1 on the supernatant [63]. Added evidence demonstrated that not only do some whey proteins exhibit an association capacity towards AFM1 similar to that of casein but also that each protein is bound to AFM1 at different ratio. Furthermore, we have also demonstrated a similar behaviour among casein fractions. In decreasing order of association or affinity towards AFM1: alphas (100%), beta (54.5%), and kappa casein (21.4%) [63]. This last result is interesting since the major biochemical modification suffered by casein during cheese clotting during its processing is an enzymatic hydrolysis of the kappa fraction. On the other hand, highly unspecific proteolytic enzymes (e.g., pepsin) can reduce AFM1-protein interactions. A protease such as the one used during our survey [45] can hydrolyse ≥ 70% of casein to amino acids and has demonstrated a more efficient cleavage of casein than other proteases such as trypsin or chymotrypsin. Such data may explain Barbiroli and co-workers [64] results which indicated that no changes in AFM1 concentration were observed during the enzymatic hydrolysis that occurred during the cheese-making process.

Evidence of AFM1 binding suggests another application of purified whey proteins as modulator of toxicity toward animals and may hold potential for protecting animals against AFM1toxigenic potential and to minimize the possibility of this or other toxic metabolites to reach the human food supply. When naturally contaminated milk is treated to obtain processed foods, a significant fraction of the whey may be contaminated with AFM1. Later, it is important to keep in mind that whey and related components (due to known nutritional value and health benefits related to consumption) already have several commercial uses as a dietary in-feed supplement, nutritional supplement, and whey-based beverages.

In the same regard, Cattaneo and coworkers recently demonstrated that during ricotta cheese (a whey based product) production, AFM1 retained ca. 6% of its initial concentration and the remainder is lost in the liquid portion [65]. The same authors showed some insights toward interaction of AFM1 and whey proteins, supporting our findings [63]. For example, the authors demonstrate that during a simple ultrafiltration step, at least 60–80% of the toxin is lost in permeate and that technological processes such as spray-drying do reduce AFM1 contamination levels in pulverized milk solids despite substantial loss of water.

3.2. An in silico analysis to estimate AFM1-protein interaction

In addition to the direct evidence of the AFM1 molecular interactions that occur during its association with proteins, an in silico analysis shows several interesting features regarding this phenomenon. When a MM2 energy optimized molecule of AFM1 is docked (cluster typed as small molecule-protein, with a clustering RMSD of 4.0) with β-lactoglobulin (1BEB) and α-lactalbumin (1CJ5), both from Bos taurus, the result is several simulations with high scores. Such models demonstrate that a considerable number of protein sites are capable — at least theoretically— to bind ound AFM1. Hence, a single protein molecule could bind a large number of AFM1 molecules; this seems to be in agreement with the macroscopic behavior of AFM1 when associated with dairy proteins. For example, the highest score prediction for α-lactalbumin (a calcium-binding lysozyme-like protein, [66]) occurs in the pocket amongst two β turns and a β sheet, that are, 161 His and 155 Gln/158 Glu coil and the 61 Trp and 151 Phe β strands (Figure 2).

Figure 2.

Depiction of possible interactions between AFM1 and A,B α-lactalbumin or C,D β-lactoglobulin, only the with the highest score is shown. Panels A and C show the spatial interaction of the molecule with the protein (ribbon cartoon representation). Panels B and D demonstrate amino acid residues, represented in red. In all panels, AFM1 is illustrated in dark blue/cyan using ball and stick models. In panels C and D water molecules are represented using green wireframes [67].

The case of β-lactoglobulin — composed of two subunits under physiological conditions — is more complicated. β-Lactoglobulin is a major whey protein of ruminant species and has been found in milk from other species. Its amino acid sequence and three-dimensional structure show that it is a lipocalin. The more energy stable prediction situates the AFM1 molecule between the 5 Gln, 6 Thr, 177 Leu β strands and the 144 Pro coil of the A chain. But other interactions sites are possible. For example, another prediction may occur in the hydrophobic crevasse between the two α-loops. A detailed look on the tridimensional structure of β-lactoglobulin may be found in a work written by Sawyer [68].

Needless to say, this is a rough prediction considering the complexity of the interactions that may occur during AFM1-protein interaction within a complex matrix such as milk. For example, casein is found in a micellar structure behaviour which, besides considering calcium ions and hydrophobic interactions that held together, such micelles must bear in mind ligand competition (dominated by Kf) and other substrates (e.g. citric acid). Protein-protein and protein-water interactions also play a distinct role in the association with AFM1. Interestingly, the binding capabilities of β-lactoglobulin have been described previously with other ligands (i.e. SDS and lipophilic molecules such as retinol, cholesterol, palmitate, and vitamin D2) through a central binding cavity [69]. One relevant feature that distinguishes β-lactoglobulin from α-lactalbumin is that, in pure form, the latter will not form gels upon denaturation because no free thiol groups are available as starting-point for a covalent aggregation reaction. Noteworthy, α-Lactalbumin surpass β-lactoglobulin in affinity towards AFM1 [63], such structural differences may explain the dissimilarities described here-in.

The interaction abilities of proteins with small molecules, such as AFM1, must be influenced by several factors such as water absorption, protein concentration, pH, ionic strength, temperature, and the presence of other components of feed or food (e.g. saccharides, lipids and salts, rate and length of heat treatment, and conditions of storage). For example, whey proteins are usually more stable towards pH changes but sensitive to heat.


4. Aflatoxin distribution dependence in dairy processing

4.1. Evidence through cheese manufacturing

The interaction between AFM1 and casein has been described more in detail above. However, evidence indicates that, during cheese production, part of the AFM1 concentration is exuded with whey. Nevertheless, up to this date, little information is available regarding the possible interaction of AFM1 with the proteins that remain in this aqueous fraction. Results of several investigations on the stability of AFM1 throughout cheese making and cheese ripening reported increase in AFM1 concentration in cheese, as a function of cheese type, technologies applied, and the amount of water eliminated during processing [30].

Some authors showed high AFM1 concentration in curd regardless of the cheese-making procedures employed [59, 62]. However, other evidence suggests that the retained AFM1 fraction by casein or other dairy proteins is highly dependent on the manufacturing process of the cheese, for example, Cavallarin and coworkers demonstrated a direct correlation between AFM1 found in milk and the levels later found in cheese [70]. A particular relationship was attained for each cheese which reinforced that manufacturing process and chemical composition of each cheese impacts the retention of AFM1. In their report, Cavallarin and co-workers discussed three different type of cheese (i.e. Robiola and Primosale, two kinds of fresh cheese, and Maccagno, a matured cheese); the distribution and fate of AFM1 was investigated preparing these cheese type using naturally and artificially contaminated milk at three different concentration levels. The authors reported that concentration factors for fresh and matured cheese were of 1.42/2.20 and 6.71, respectively. Our data regarding a survey [45] in milk and fresh cheese indicate that contrary to other cases, Turrialba cheese exhibited consistently lower average concentrations of AFM1 when compared with those found in milk. Such data suggest that fresh or whey-based cheese (which sustains much less treatment than matured ones) is less prone in concentrating AFM1.

In protein chemistry, physicochemical factors such as pH, temperature, and ion concentration play a significant role in protein behavior. The collective action of thermal processing and pH can denature dairy proteins to such extent that they may be able to lose AFM1 binding capacity [64], agreeing with our current results [63]. Hence, lower pH in the water portion or the final product may explain why in certain cheese types a differential partitioning is observed. For example, lower AFM1 concentrations may be found in whey fraction when comparing different processing treatments [70].

In a similar fashion, Piera Cattaneo and coworkers [65] demonstrated that AFM1 retention and distribution in Ricotta cheese is also dependent on processing and manufacturing. For example, ultrafiltration and spray-drying can contribute to reducing, in a significant manner, AFM1 concentrations from contaminated whey. The latter fact contributes to our understanding of AFM1 regarding technological processes and unit operations especially since the toxin is thermally stable.

In 2013, Motawee contended several points concerning Domiati cheese manufacturing. First, confirming other data, pasteurization reduced < 10% of the AFM1; second, salting seems to affect the retention of AFM1 in curd; third after a 90-day preservation of cheese, the initial concentration of AFM1was reduced significantly [71]. Concordantly, findings in fresh Costa Rican cheese evidenced as high as 88.3% of AFM1 reduction during storage in a 28-day period. However, even at 4°C, Turrialba cheese exhibited signs of spoilage after one month storage [63]. In contrast, Deveci [57] already demonstrated using White Pickled cheese that AFM1 remains for up to three months of storage in brine, and that approximately 31% of the AFM1 passed to whey, while only about 3% distributes to the brine during ripening. Comparing this last result to other similar data seems to suggest that salting may prevent the subsequent loss during cheese storage possibly due to an increase in ionic strength and disruption of the interaction between toxin and protein.

In the same regard, Fernandes and co-workers [72] found that during Minas Frescal cheese manufacturing, there was no effect of storage time on AFM1. They also stated that starter culture in cheese did not influence the concentration or stability of AFM1.

On the other hand, other dairy products have been researched, for example, Iha and coworkers [73] found that yogurt processing and storage had a marginal effect on AFM1 concentration and that the total AFM1 content in cheese and whey decreased approximately 25%. The authors found an increase of AFM1 in cheese of 1.9-fold, but a decrement of 0.4-fold in whey, based on the initial aflatoxin present in the milk used for cheese manufacturing. This is an interesting result, since other research groups had established that lactic acid bacteria in dairy products has the capability of AFM1 decontamination [74]. A very thorough review of other methods of milk detoxification has been performed recently by Giovatti and coworkers [75].

4.2. AFM1 interaction with probiotic structures

As organic solvents have the ability to release aflatoxin from binding to bacterial cell walls and peptidoglycan structural components, Haskard and coworkers have suggested that hydrophobic interactions play a significant role in the binding mechanism [76]. Reversible and irreversible binding are phenomena governing aflatoxin union to bacterial and yeast binding. Reversible unions seem to suggest non-covalent interactions between aflatoxin and hydrophobic pockets on the bacterial surface [77]. Further studies demonstrated that other different lactic acid strains can bind and remove AFB1 in liquid media. Furthermore, said interaction behaves in a concentration-dependent manner [78, 79]. The mechanism for probiotic structure-AFM1 interaction may also help understand the process in which such toxins interact with macro/biomolecules.

Though the exact mechanism is still unclear, our data seems to reinforce other publications which have found decontamination capabilities specifically in cheese [80] as well in other matrices [73, 80, 81]. Previous reports [79] have already documented the interaction between teichoic acids and other bacterial cell wall components by probiotic bacteria and yeasts [82]. Interestingly, an empirical observation also seems to indicate that as the lactic acid bacteria counts increases with time, more difficulties in cheese extract/digest are going past through the immunoaffinity columns, are common, probably due to higher cellular debris. Detoxification of probiotics has been demonstrated in other milk products as well [83].

In this regard, Bovo and coworkers [80] have already established that non-viable cell counts affect toxin sequestration. Hence, one might argue that despite pasteurization of milk, bacterial structures may remain and, as such, milk non-viable microorganisms may still play a role in the results observed. One additional aspect to consider as well is that during cheese ripening, biochemical phenomena such as lipolysis and proteolysis occur which in turn may affect toxin binding capabilities [84]. As time progresses, pH changes as a function of time due to biochemical processes that cheese suffers, and in this scenario, protein-toxin interactions may transform as the electrostatic and hydrophobic forces mutate, as hydronium ion activity/concentration changes. Microbial sorption has been explored recently as a viable way to reduce AFM1 levels in milk.

Finally, the binding of AFM1 by microbial cells has been reported as a rapid process [85, 86], based on our current data in which just an incubation periods of minutes are sufficient to bind completely AFM1 to casein and whey proteins, these seems to be the issue for AFM1-protein interaction as well. However, as with proteins, evidence suggests that various strains of probiotics and different membrane components bind AFM1 differentially [79].


5. Other implications of AFM1 association with proteins

Despite being considered a by-product of cheese manufacturing, whey still preserves a rather complex composition that include proteins such as α-lactalbumin, β-lactoglobulin, serum albumin, lactoferrin and lactoperoxidase, glycomacropeptides (produced by rennets from k-casein), protease-peptones (generated by plasmin, mainly from β-casein) phosphopeptides, and other enzymes and oligopeptides as the result of hydrolysis [12], as such it retains nutritional value. Also, they are known to form gels capable of keeping different substrates (e.g. water and lipids) and providing texture properties desired for several foods [87], as such, a substantial number of commercially viable options (e.g., whey-based beverages or even whey based fitness supplements) have been developed [88]. Hence, the evidence up to date supports that there is in fact an implied risk of contaminated products to reach the customer. Another example lies in β-lactoglobulin fibrils. These structures are aggregates formed by incubation of β-lactoglobulin in various solvents with protein-denaturing capabilities, (usually wormlike ca. 7 nm in width and < 500 nm in length), with a “bead string” form [89], and are nowadays very prevalent in the food industry to increase viscosity and encapsulation and transport other compounds of interest [90]. Recently, Mazaheri and co-workers have demonstrated that β-lactoglobulin fibrils exhibit neurotoxicity in cell culture and are capable of causing free radical formation, and that the presence of AFM1 increases this potential by favoring reactive oxygen species and causes non-trivial modifications in the protein structure [91].


6. Perspectives and conclusions

AFM1 has the capability to interact with macromolecules, including proteins. These interactions are dependent on many factors which also affect the already complex protein chemistry. Milk and dairy products which are complex biological fluids usually bear considerable concentrations of proteins. Recent evidence points toward a broad binding capability of milk proteins including casein and whey proteins. These interactions are affected by unit operations and technological processing. Based on the latest advances in molecule discrimination such as X-ray crystallography, NMR or atomic force microscopy could eventually help us collect more direct evidence on the occurring interactions between AFM1 and proteins at a molecular level.

Finally, AFM1 distribution, outcome, and interaction with different dairy ingredients are not to be ignored, particularly considering the recent findings regarding the behaviour of AFM1 in milk products and by-products. This is especially important for products which once were considered process wastes (such as whey and related products) since now they are known to be used in animal feeding, as nutritional supplements destined for human consumption and even in the snack food industry. Therefore, whey AFM1 contaminated products may serve a way to incorporate toxins within the food chain. Evidence supports the fact that dairy processing does influence AFM1 concentrations.



I would like to thank Graciela Artavia for her assistance during the rendering of the 3D simulations and Carlos Arias, Alfredo Guerra and Geovanna Méndez for their valuable suggestions during the preparation of this chapter. Financial support was received from Vicerrectoría de Investigación. valuable suggestions during the preparation of this chapter.


  1. 1. W.N. Eigel, J.E. Butler, C.A. Ernstrom, H.M. Farrell Jr., V.R. Harwalkar, R. Jenness, R. McL. Whitney. Nomenclature of proteins of cow's milk: Fifth revision. Journal of Dairy Science. 1984;67(8):1599–1631. DOI: 10.3168/jds.S0022-0302(84)81485-X
  2. 2. H.W. Modler. Functional properties of nonfat dairy ingredients - A review. Modification of products containing casein. Journal of Dairy Science. 1985;68(9):2195–2205. DOI: 10.3168/jds.S0022-0302(85)81091-2
  3. 3. M.B. Rao, A.M. Tanksale, M.S. Ghatge, V.V. Deshpande. Molecular and biotechnological aspects of microbial proteases. Microbiology and Molecular Biology Reviews. 1998;62(3):597–635.
  4. 4. K. Gellrich, H.H.D. Meyer, S. Wiedemann. Composition of major proteins in cow milk differing in mean protein concentration during the first 155 days of lactation and the influence of season as well as short-term restricted feeding in early and mid-lactation. Czech Journal of Animal Science. 2014;59(3):97–106.
  5. 5. D.S. Horne. Casein interactions: Casting light on the black boxes, the structure of dairy. International Dairy Journal. 1998;8(3):171–177. DOI: 10.1016/S0958-6946(98)00040-5
  6. 6. D.S. Horne. Casein structure, self-assembly and gelation. Current Opinion in Colloid & Interface Science. 2002;7(5–6):456–461. DOI: 10.1016/S1359-0294(02)00082-1
  7. 7. D.S. Horne. Casein micelle structure: Models and muddles. Current Opinion in Colloid & Interface Science. 2006;11(2–3):148–153. DOI: 10.1016/j.cocis.2005.11.004
  8. 8. D.S. Horne. Casein, molecular structure. In: J.W. Fuquay, P.F. Fox, P.L.H. McSweeney, editors. Encyclopedia of Dairy Sciences. 2nd ed. Oxford, UK: Academic Press; 2011. pp. 772–779.
  9. 9. D.S. Horne. Casein micelle structure and stability. In: H. Singh, M. Boland, A. Thompson, editors. Milk Proteins: From Expression to Food. 2nd ed. Amsterdam, Netherlands: Elsevier; 2014. pp. 169–200.
  10. 10. P.F. Fox. Lactose: Chemistry, properties. In: P.L.H. McSweeney, P.F. Fox, editors. Advanced Dairy Chemistry. 3rd ed. Oxford, UK: Academic Press; 2009. pp. 1–15. DOI: 10.1007/978-0-387-84865-5_1
  11. 11. D. Duppont, R. Grappin, S. Pochet, D. Lefier. Milk proteins: Analytical methods. In: J.W. Fuquay, P.F. Fox, P.L.H. McSweeney, editors. Encyclopedia of Dairy Sciences. 2nd ed. Oxford, UK: Academic Press; 2011. pp. 741–750.
  12. 12. P.F. Fox, T. Uniacke-Lowe, P.L.H. McSweeney, J.A. O’Mahony. Dairy Chemistry and Biochemistry. 2nd ed. Switzerland: Springer International Publishing; 2015. 584 p. DOI: 10.1007/978-3-319-14892-2
  13. 13. A. Kamkar, G.R. Jahed Khaniki, S.A. Alavi. Occurrence of aflatoxin M1 in raw milk produced in Ardabil of Iran. Iranian Journal of Environmental Health Science and Engineering. 2011;8(2):123–128.
  14. 14. A.A. Fallaha, A. Baranic, Z. Nasiri. Aflatoxin M1 in raw milk in Qazvin Province, Iran: A seasonal study. Food Additives & Contaminants: Part B: Surveillance. 2015;8(3):195–198. DOI: 10.1080/19393210.2015.1046193
  15. 15. J. Yu. Current understanding on aflatoxin biosynthesis and future perspective in reducing aflatoxin contamination. Toxins. 2012;4(11):1024–1057. DOI: 10.3390/toxins4111024
  16. 16. G.S. Bbosa, D. Kitya, A. Lubega, J. Ogwal-Okeng, W.W. Anokbonggo, D.B. Kyegombe. Review of the biological and health effects of aflatoxins on body organs and body systems. In: M. Razzaghi-Abyaneh, editor. Aflatoxins – Recent Advances and Future Prospects. 1st ed. Rijeka, Croatia: InTech; 2013. pp. 239–265. DOI: 10.5772/51201
  17. 17. M. Britzi, S. Friedman, J. Miron, R. Solomon, O. Cuneah, J.A. Shimshoni, S. Soback, R. Ashkenazi, S. Armer, A. Shlosberg. Carry-over of aflatoxin B1 to aflatoxin M1 in high yielding Israeli cows in mid- and late lactation. Toxins. 2013;5(1):173–183. DOI: 10.3390/toxins5010173
  18. 18. N. Sultana, N.Q. Hanif. Mycotoxin contamination in cattle feed and feed ingredients. Pakistan Veterinary Journal. 2009;29(4):211–213.
  19. 19. A. Zarba, C.P. Wild, A.J. Hall, R. Montesano, G.J. Hudson, J.D. Groopman. Aflatoxin M1 in human breast milk from the Gambia, West Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC. Carcinogenesis. 1992;13(5):891–894.
  20. 20. A. Veldmana, J.A.C. Meijsa, G.J. Borggrevea, J.J. Heeres-van der Tola. Carry-over of aflatoxin from cows' food to milk. Animal Production. 1992;55(02):163–168. DOI: 10.1017/S0003356100037417
  21. 21. EFSA Panel on Contaminants in the Food Chain. Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to aflatoxin B1 as undesirable substance in animal feed. The EFSA Journal. 2004;39:1–27. DOI: 10.2903/j.efsa.2004.39
  22. 22. International Agency for Research on Cancer. Chemical agents and related compounds. IARC Monographs. 2012;100F:225–244.
  23. 23. P.X. Qi, D. Ren, Y. Xiao, P. M. Tomasula. Effect of homogenization and pasteurization on the structure and stability of whey protein in milk. Journal of Dairy Science. 2015;98(5):2884–2897. DOI: 10.3168/jds.2014-8920
  24. 24. S.K. Sharma, D.G. Dalgleish. Interactions between milk serum proteins and synthetic fat globule membrane during heating of homogenized whole milk. Journal of Agricultural and Food Chemistry. 1993;41(9):1407–1412. DOI: 10.1021/jf00033a011
  25. 25. H. Mohammadi. A review of aflatoxin M1, milk, and milk products. In: R.G. Guevara-Gonzalez, editor. Aflatoxins – Biochemistry and Molecular Biology. 1st ed. Rijeka, Croatia: InTech; 2011. pp. 397–415.
  26. 26. T. Şanli, O. Devecií, E. Sezgín. Effects of pasteurization and storage on stability of aflatoxin M1 in yogurt. Kafkas Univ Vet Fak Derg. 2012;18(6):987–990. DOI: 10.9775/kvfd.2012.6887
  27. 27. F. Bosco, C. Mollea. Mycotoxins in food. In: Valdez B., editor. Food Industrial Processes, Methods and Equipment. 1st ed. Rijeka, Croatia: InTech; 2012. pp. 169–200.
  28. 28. F. Galvano, V. Galofaro, A. Ritieni, M. Bognanno, A. De Angelis. Survey of the occurrence of aflatoxin M1 in dairy products marketed in Italy. Journal of Food Protection. 1998;61(6):738–741.
  29. 29. M. Carvajal, A. Bolaños, F. Rojo, I. Méndez. Aflatoxin M1 in pasteurized and ultrapasteurized milk with different fat content in Mexico. Journal of Food Protection. 2003;66(10):1885–1892.
  30. 30. L. Anfossi, C. Baggiani, C. Giovannoli, G. Giraudi. Occurrence of Aflatoxin M1 in Dairy Products. In: I. Torres-Pacheco, editor. Aflatoxins – Detection, Measurement and Control. 1st ed. Rijeka, Croatia: InTech; 2012. pp. 3–21. DOI: 10.5772/22724
  31. 31. International Standarization Office, International Dairy Federation. Milk and milk powder - Determination of aflatoxin M1 content - Clean-up by immunoaffinity chromatography and determination by high-performance liquid chromatography. ISO 14501. 2007;IDF 171:1–10.
  32. 32. S. Dragacci, F. Grosso, J. Gilbert. Aflatoxin M1 in liquid milk: Immunoaffinity column by liquid chromatography. Journal of AOAC International. 2001;84(2):437–443.
  33. 33. F. de Zayas-Blanco, M.S. García-Falcón, J. Simal-Gandara. Determination of sulfamethazine in milk by solid phase extraction and liquid chromatographic separation with ultraviolet detection. Food Control. 2004;15(5):375–378. DOI: 10.1016/S0956-7135(03)00100-2
  34. 34. E.V. Reiter, M. Cichna-Mark, D-H. Chung, J. Zentek, E. Razzazi-Fazeli. Immuno-ultrafiltration as a new strategy in sample clean-up of aflatoxins. Journal of Separation Science. 2009;32(10):1729–1739. DOI: 10.1002/jssc.200900123
  35. 35. S.Z. Iqbala, S. Jinapab, A. Perozab, A.F. Abdull Razis. Aflatoxin M1 in milk and dairy products, occurrence and recent challenges: A review. Trends in Food Science & Technology. 2015;46(1):110–119. DOI: 10.1016/j.tifs.2015.08.005
  36. 36. M.B. Yitbareka, B. Tamir. Mycotoxines and/or aflatoxines in milk and milk products: Review. American Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS). 2013;4(1):1–32.
  37. 37. M. Hashemi, Z. Taherimaslaka. Determination of aflatoxin M1 in liquid milk using high performance liquid chromatography with fluorescence detection after magnetic solid phase extraction. RSC Advances. 2014;4(63):33497–33506. DOI: 10.1039/C4RA04254A
  38. 38. L. Campone, A.L. Piccinelli, R. Celano, I. Pagano, M. Russo, L. Rastrelli. Rapid and automated analysis of aflatoxin M1 in milk and dairy products by online solid phase extraction coupled to ultra-high-pressure-liquid-chromatography tandem mass spectrometry. Journal of Chromatography A. 2015;1428(8):212–219. DOI: 10.1016/j.chroma.2015.10.094
  39. 39. L.C. Huang, N. Zheng, B.Q. Zheng, F. Wen, J.B. Cheng, R.W. Han, X.M. Xu, S.L. Li, J.Q. Wang. Simultaneous determination of aflatoxin M1, ochratoxin A, zearalenone and α-zearalenol in milk by UHPLC-MS/MS. Food Chemistry. 2014;146(1):242–249. DOI: 10.1016/j.foodchem.2013.09.047
  40. 40. Y. Wang, X. Liu, C. Xiao, Z. Wang, J. Wang, H. Xiao, L. Cui, Q. Xiang, T. Yue. HPLC determination of aflatoxin M1 in liquid milk and milk powder using solid phase extraction on OASIS HLB. Food Control. . 2012;28(1):131–134. DOI : 10.1016/j.foodcont.2012.04.037
  41. 41. W. Boonjob, H. Sklenarova, F.J. Lara, M. García-Campaña, P. Solich. Retention and selectivity of basic drugs on solid-phase extraction sorbents: Application to direct determination of β-blockers in urine. Analytical and Bioanalytical Chemistry. 2014;406(17):4207–4215. DOI: 10.1007/s00216-014-7753-4
  42. 42. X. Ma, W. Ji, L. Chen, X. Wang, J. Liu, X. Wang. Molecularly imprinted polymers with synthetic dummy templates for the preparation of capsaicin and dihydrocapsaicin from chili peppers. Journal of Separation Science. 2014;38(1):100–107. DOI: 10.1002/jssc.201400911
  43. 43. S. Wei, Y. Liu, Z. Yana, L. Liu. Molecularly imprinted solid phase extraction coupled to high performance liquid chromatography for determination of aflatoxin M1 and B1 in foods and feeds. RSC Advances. 2015;5(27):20951–20960. DOI: 10.1039/C4RA16784H
  44. 44. M. Castegnaro, M. Tozlovanu, C. Wild, A. Molinié, A. Sylla, A. Pfohl-Leszkowicz. Advantages and drawbacks of immunoaffinity columns in analysis of mycotoxins in food. Molecular Nutrition & Food Research. 2006;50(6):480–487. DOI: 10.1002/mnfr.200500264
  45. 45. G. Chavarría, F. Granados-Chinchilla, M. Alfaro-Cascante, A. Molina. Detection of aflatoxin M1 in milk, cheese and sour cream samples from Costa Rica using enzyme-assisted extraction and HPLC. Food Additives & Contaminants: Part B: Surveillance. 2015;8(2):128–135. DOI: 10.1080/19393210.2015.1015176
  46. 46. A. Pietri, P. Fortunati, A. Mulazzi, T. Bertuzzi. Enzyme-assisted extraction for the HPLC determination of aflatoxin M1 in cheese. Food Chemistry. 2016;192:235–241. DOI: 10.1016/j.foodchem.2015.07.006
  47. 47. Y. Wang, N. Liu, B. Ning, M. Liu, Z. Lv, Z. Sun, Y. Peng, C. Chena. Simultaneous and rapid detection of six different mycotoxins using an immunochip. Biosensors and Bioelectronics. 2012;34:44–50. DOI: 10.1016/j.bios.2011.12.057
  48. 48. X. Zhanga, C-R. Lia, W-C. Wanga, J. Xuea, Y-L. Huanga, X-X. Yanga, B. Tana, X-P. Zhoua, C. Shaob, S-J. Dingc, J-F. Qiua. A novel electrochemical immunosensor for highly sensitive detection of aflatoxin B1 in corn using single-walled carbon nanotubes/chitosan. Food Chemistry. 2016;192:197–202. DOI: 10.1016/j.foodchem.2015.06.044
  49. 49. V.K. Singh, N.A. Singh, N. Kumar, H.V. Raghu, P.K. Sharma, K.P. Singh, A. Yadava. Spore immobilization and its analytical performance for monitoring of aflatoxin M1 in milk. Canadian Journal of Microbiology. 2014;60(12):793–798. DOI: 10.1139/cjm-2014-0465
  50. 50. L. Anfossi, C. Baggiani, C. Giovannoli, F. Biagioli, G. D'Arco, G. Giraudi. Optimization of a lateral flow immunoassay for the ultrasensitive detection of aflatoxin M1 in milk. Analytica Chimica Acta. 2013;772:75–80. DOI: 10.1016/j.aca.2013.02.020
  51. 51. A. Adami, A. Mortari, E. Morganti, L. Lorenzelli. Microfluidic sample preparation methods for the analysis of milk contaminants. Journal of Sensors. 2016;2016:2385267. DOI: 10.1155/2016/2385267
  52. 52. F. Galvano, V. Galofaro, A. Ritieni, M. Bognanno, A. De Angelis. Survey of the occurrence of aflatoxin M1 in dairy products marketed in Italy: second year of observation. Food Additives and Contaminants. 2001;18(7):644–646.
  53. 53. R.E. Brackett, E.H. Marth. Association of aflatoxin M1 with casein. European Food Research and Technology A. 1982;174(6):439 –441. DOI: 10.1007/BF01042721
  54. 54. C. Mendonça, A. Venâncio. Fate of aflatoxin M1 in cheese whey processing. Journal of the Science of Food and Agriculture. 2005;85(12):2067–2070. DOI: 10.1002/jsfa.2218
  55. 55. E.C. Pappa, G.K. Zerfiridis. Teleme cheese. In: Y.H. Hui, editor. Handbook of Animal-Based Fermented Food and Beverage Technology. 2nd ed. Boca Ratón, FL: CRC Press; 2012. pp. 269–284.
  56. 56. H.H. Oruc, R. Cibik, E. Yikmaz, O. Kalkanli. Distribution and stability of aflatoxin M1 during processing and ripening of traditional white pickled cheese. Food Additives and Contaminants. 2006;23(2):190–195.
  57. 57. O. Deveci. Changes in the concentration of aflatoxin M1 during manufacture and storage of white pickled cheese. Food Control. 2007;18(9):1103–1107. DOI: 10.1016/j.foodcont.2006.07.012
  58. 58. A. Kamkar. The study of aflatoxin M1 in UHT milk samples by ELISA. Journal of Veterinary Research. 2008;63(2):7–12.
  59. 59. A.C. Manetta, M. Giammarco, L. Di Giuseppe, I. Fusaro, A. Gramenzi, A. Formigoni, G. Vignola, L. Lambertini. Distribution of aflatoxin M1 during Grana Padano cheese production from naturally contaminated milk. Food Chemistry. 2009;113:595–599.
  60. 60. A. Prandini, G. Tansini, S. Sigolo, L. Filippi, M. Laporta, G. Piva. Review: On the occurrence of aflatoxin M1 in milk and dairy products. Food and Chemical Toxicology. 2009;47:984–991.
  61. 61. H.H. Colak, B.B. Enver, O. Cetin, A. Meryem, S.I. Turgay. Determination of mould and aflatoxin contamination in Tarhana, a Turkish fermented food. Scientific World Journal. 2012;2012:218679. DOI: 10.1100/2012/218679
  62. 62. M.M. Motawee, D.J. McMahon. Fate of aflatoxin M1 during manufacture and storage of feta cheese. Journal of Food Science. 2009;74(5):42–45.
  63. 63. G. Chavarría, A. Molina, A. Leiva, G. Méndez, E. Wong-González, M. Cortés-Muñoz, C. Rodríguez, Fabio Granados-Chinchilla. Distribution, stability, and protein-interactions of Aflatoxin M1 in fresh cheese. 2016; Manuscript in preparation.
  64. 64. A. Barbiroli, F. Bonomi, S. Benedetti, S. Mannino, L. Monti, T. Cattaneo, S. Iametti. Binding of aflatoxin M1 to different protein fractions in ovine and caprine milk. Journal of Dairy Science. 2007;90(2):532–540. DOI: 10.3168/jds.S0022-0302(07)71536-9
  65. 65. T.M. Piera Cattaneo, L. Marinoni, S. Iametti, L. Monti. Behavior of aflatoxin M1 in dairy wastes subjected to different technological treatments: Ricotta cheese production, ultrafiltration and spray-drying. Food Control. 2013;32(1):77–82. DOI: 10.1016/j.foodcont.2012.11.007
  66. 66. K.R. Acharya, D.I. Stuart, N.P. Walker, M. Lewis, D.C. Phillips. Refined structure of baboon alpha-lactalbumin at 1.7 A resolution. Comparison with C-type lysozyme. Journal of Molecular Biology. 1989;208(1):99–127. DOI: 10.1016/0022-2836(89)90091-0
  67. 67. D. Schneidman-Duhovny, Y. Inbar, R. Nussinov, H.J. Wolfson. PatchDock and SymmDock: Servers for rigid and symmetric docking. Nucleic Acids Research. 2005;33:363–367.
  68. 68. L. Sawyer. β-Lactoglobulin. In: P.L.H. McSweeney, P.F. Fox, editors. Advanced Dairy Chemistry. Proteins: Basic Aspects. 4th ed. New York, NY: Springer; 2013. pp. 211–259.
  69. 69. G. Kantopidis, C. Holt, L. Sawyer. Invited review: Beta-lactoglobulin: Binding properties, structure and function. Journal of Dairy Science. 2004;87:785–796.
  70. 70. L. Cavallarin, S. Antoniazzi, D. Giaconne, E. Tabacco, G. Borreani. Transfer of aflatoxin M1 from milk to ripened cheese in three Italian traditional production methods. Food Control. 2014;38:174–177.
  71. 71. M. M. Motawee. Reduction of aflatoxin M1 content during manufacture and storage of Egyptian domaiti cheese. International Journal of Veterinary Medicine: Research & Reports. 2013;2013:207299.
  72. 72. A.M. Fernandes, B. Corrêa, R.E. Rosim, E. Kobashigawa, C.A.F. Oliveira. Distribution and stability of aflatoxin M1 during processing and storage of Minas Frescal cheese. Food Control. 2012;24(1–2):104–108. DOI: 10.1016/j.foodcont.2011.09.010
  73. 73. M.H. Iha, C.B. Barbosa, I.A. Okada, M.W. Trucksess. Aflatoxin M1 in milk and distribution and stability of aflatoxin M1 during production and storage of yoghurt and cheese. Food Control. 2013;29(1):1–6. DOI: 10.1016/j.foodcont.2012.05.058
  74. 74. F. Bovo, L.T. Franco, R.E. Rosim, C.A.F. de Oliveira. Efficiency of different sources of Saccharomyces cerevisiae to bind aflatoxin B1 in phosphate buffer saline. Food Science and Technology. 2014;34(3):566–570.
  75. 75. L. Giovati, W. Magliani, T. Ciociola, C. Santinoli, S. Conti, L. Polonelli. AFM1 in milk: Physical, biological, and prophylactic methods to mitigate contamination. Toxins. 2015;7(10):4330–4349. DOI: 10.3390/toxins7104330
  76. 76. C. Haskard, C. Binnion, J. Ahokas. Factors affecting the sequestration of aflatoxin by Lactobacillus rhamnosus strain GG. Chemico-Biological Interactions. 2000;128(1):39–49. DOI: 10.1016/S0009-2797(00)00186-1
  77. 77. C.A. Haskard, H.S. El-Nezami, P.E. Kankaanpää, S. Salminen, J.T. Ahokas. Surface binding of aflatoxin B1 by lactic acid bacteria. Applied and Environmental Microbiology. 2001;67(7):3086–3091. DOI: 10.1128/AEM.67.7.3086-3091.2001
  78. 78. K. Peltonen, H. El-Nezami, C. Haskard, J. Ahokas, S. Salminen. Aflatoxin B1 binding by dairy strains of lactic acid bacteria and bifidobacteria. Journal of Dairy Science. 2001;84(10):2152–2156.
  79. 79. A. Hernández-Mendoza, H.S. García, J.L. Steele. Screening of Lactobacillus casei strains for their ability to bind aflatoxin B1. Food Chemistry and Toxicology. 2009;47(6):1064–1068.
  80. 80. C.H. Corassin, F. Bovo, R.E. Rosim, C.A.F. Oliveira. Efficiency of Saccharomyces cerevisiae and lactic acid bacteria strains to bind aflatoxin M1 in UHT skim milk. Food Control. 2013;31(1):80–83. DOI: 10.1016/j.foodcont.2012.09.033
  81. 81. A. Zinedine, M. Faid, M. Benlemlih. In vitro reduction of aflatoxin B1 by strains of lactic acid bacteria isolated from Moroccan sourdough bread. International Journal of Agriculture and Biology. 2005;7(1):67–70.
  82. 82. B.L. Gonçalves, R.E. Rosim, C.A.F. de Oliveira, C.H. Corassin. The in vitro ability of different Saccharomyces cerevisiae – Based products to bind aflatoxin B1. Food Control. 2015;47:298–300. DOI: 10.1016/j.foodcont.2014.07.024
  83. 83. R.M. Elsanhotya, S.A. Salama, M.F. Ramadanc, F.H. Badre. Detoxification of aflatoxin M1 in yoghurt using probiotics and lactic acid bacteria. Food Control. 2014;43:129–134. DOI: 10.1016/j.foodcont.2014.03.002
  84. 84. P.L.H. McSweeney. Biochemistry of cheese ripening. International Journal of Dairy Technology. 2004;57(2–3):127–144. DOI: 10.1111/j.1471-0307.2004.00147.x
  85. 85. J.C. Serrano-Niño, A. Cavazos-Garduño, A. Hernández-Mendoza, B. Applegatec, M.G. Ferruzzic, M.F. San Martin-Gonzálezc, H.S. García. Assessment of probiotic strains ability to reduce the bioaccessibility of aflatoxin M1 in artificially contaminated milk using an in vitro digestive model. Food Control. 2013;31(1):202–207. DOI: 10.1016/j.foodcont.2012.09.023
  86. 86. B. Kabak, I. Var. Factors affecting the removal of aflatoxin M1 from food model by lactobacillus and bifidobacterium strains. Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes. 2008;43(7):617–624. DOI: 10.1080/03601230802234740
  87. 87. M. Outinen, P. Rantamäki, A. Heino. Effect of milk pretreatment on the whey composition and whey powder functionality. Journal of Food Science. 2010;75(1):E1–10. DOI: 10.1111/j.1750-3841.2009.01382.x
  88. 88. B.H. Özer, H.A. Kirmaci. Functional milks and dairy beverages. International Journal of Dairy Technology. 2010;63(1):1–15. DOI: 10.1111/j.1471-0307.2009.00547.x
  89. 89. W.S. Gosal, A.H. Clark, S.B. Ross-Murphy. Fibrillar β-lactoglobulin gels:  Part 1. Fibril formation and structure. Biomacromolecules. 2004;5(6):2408–2419. DOI: 10.1021/bm049659d
  90. 90. A. Kroes-Nijboer, P. Venema, E. van der Linden. Fibrillar structures in food. Food & Function. 2012;2012(3):221–227. DOI: 10.1039/C1FO10163C
  91. 91. M. Mazaheri, A.A. Moosavi-Movahedi, A.A. Saboury, F. Khodagholi, F. Shaerzadeh, N. Sheibani. Curcumin protects β-lactoglobulin fibril formation and fibril-induced neurotoxicity in PC12 cells. PLoS One. 2015;10(7):e0133206. DOI: 10.1371/journal.pone.0133206

Written By

Fabio Granados-Chinchilla

Submitted: September 28th, 2015 Reviewed: April 4th, 2016 Published: September 7th, 2016